CRH Medical (CRH) Stock Price, News & Analysis

Company Overview

CRH Medical Corporation provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology to treat various grades of hemorrhoid. The company distributes CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to gastroenterology practices. It also offers a hemorrhoid banding ancillary program, cybersecurity, and a consumer-centric digital application. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada. As of April 22, 2021, CRH Medical Corporation operates as a subsidiary of WELL Health Technologies Corp.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 36,923 shs
• Average Volume: 190,654 shs
• Market Capitalization: C$357.38 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Materials
• Industry: Construction Materials
• Sub-Industry: Construction Materials
• Current Symbol: TSE:CRH
• CIK: N/A
• Web: investors.crhsystem.com
• Phone: +1-604-6331440
• Fax: N/A
• Employees: 77,400
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 67.81
• Current Ratio: 2.68
• Quick Ratio: 2.57

Sales & Book Value

• Annual Sales: C$106.17 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 90.73
• Book Value: C$0.75 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 71,620,000
• Free Float: N/A
• Market Cap: C$357.38 million
• Optionable: Not Optionable
• Beta: N/A